HomeXENE • NASDAQ
add
Xenon Pharmaceuticals Inc
Previous close
$39.25
Day range
$38.34 - $39.81
Year range
$27.99 - $50.99
Market cap
2.98B USD
Avg Volume
430.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 14.79M | 55.12% |
Net income | -47.93M | -14.87% |
Net profit margin | — | — |
Earnings per share | -0.62 | 1.59% |
EBITDA | -58.44M | -20.01% |
Effective tax rate | -0.87% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 699.60M | 32.74% |
Total assets | 919.02M | 27.67% |
Total liabilities | 31.32M | -4.86% |
Total equity | 887.70M | — |
Shares outstanding | 75.47M | — |
Price to book | 3.34 | — |
Return on assets | -15.67% | — |
Return on capital | -16.07% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -47.93M | -14.87% |
Cash from operations | -43.18M | -25.48% |
Cash from investing | -46.20M | -199.10% |
Cash from financing | — | — |
Net change in cash | -89.75M | -831.43% |
Free cash flow | -32.89M | -28.82% |
About
Founded
1996
Headquarters
Website
Employees
255